JF
RARE icon

Jump Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

Jump Financial’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Buy
504,143
+388,215
+335% +$8.74M 0.14% 163
2025
Q4 		$2.67M Buy
115,928
+58,460
+102% +$1.92M 0.03% 573
2025
Q3 		$1.73M Buy
57,468
+25,795
+81% +$774K 0.02% 781
2025
Q2 		$1.15M Buy
31,673
+5,158
+19% +$186K 0.01% 918
2025
Q1 		$960K Sell
26,515
-86,301
-76% -$3.59M 0.01% 840
2024
Q4 		$4.75M Buy
112,816
+87,825
+351% +$4.36M 0.1% 273
2024
Q3 		$1.39M Sell
24,991
-2,298
-8% -$117K 0.03% 658
2024
Q2 		$1.12M Buy
+27,289
New +$1.17M 0.02% 767
2023
Q4 		– Sell
-23,436
Closed -$835K – 2160
2023
Q3 		$835K Buy
23,436
+6,295
+37% +$249K 0.03% 762
2023
Q2 		$791K Buy
17,141
+2,803
+20% +$130K 0.03% 811
2023
Q1 		$575K Sell
14,338
-40,968
-74% -$1.76M 0.02% 826
2022
Q4 		$2.56M Buy
55,306
+43,508
+369% +$1.71M 0.13% 199
2022
Q3 		$489K Buy
+11,798
New +$606K 0.02% 912

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Jump Financial's RARE Position: Q1 2026 in Review

Jump Financial increased its Ultragenyx Pharmaceutical (RARE) stake by 335% in Q1 2026, buying an estimated $8.74M and bringing the position to 504,143 shares worth $10.6M. The position accounts for 0.14% of the portfolio, ranked #163.

Jump Financial first reported a position in RARE in Q3 2022 and has held it in 13 quarters since. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Jump Financial held 504,143 shares of Ultragenyx Pharmaceutical worth $10.6M as of Q1 2026.
  • Jump Financial bought 388,215 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $8.74M.
  • Ultragenyx Pharmaceutical made up 0.14% of Jump Financial's portfolio in Q1 2026, its #163 holding.
  • Jump Financial first reported a position in Ultragenyx Pharmaceutical in Q3 2022 and has held it in 13 quarters since.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.